Similar articles

• Genomic landscape of gastric cancer: molecular classification and potential targets.

  Guo J, Yu W, Su H, Pang X. Guo J, et al. Sci China Life Sci. 2017 Feb;60(2):126-137. doi: 10.1007/s11427-016-0034-1. Epub 2016 Jul 26. Sci China Life Sci. 2017. PMID: 27460193 Review.
• Preferential occurrence of RHOA mutation in gastric and colorectal cancers.

  Kim MS, Yoo NJ, Lee SH. Kim MS, et al. Pathology. 2015 Oct;47(6):598-9. doi: 10.1097/PAT.0000000000000305. Pathology. 2015. PMID: 26352114 No abstract available.
• Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.

  Miyamoto S, Nagamura Y, Nakabo A, Okabe A, Yanagihara K, Fukami K, Sakai R, Yamaguchi H. Miyamoto S, et al. Biochem Biophys Res Commun. 2018 Jan 8;495(2):1942-1947. doi: 10.1016/j.bbrc.2017.12.067. Epub 2017 Dec 13. Biochem Biophys Res Commun. 2018. PMID: 29247652
• Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma.

  Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, Ichimura T, Ushiku T, Funahashi S, Tateishi K, Wada I, Shimizu N, Nomura S, Koike K, Seto Y, Fukayama M, Aburatani H, Ishikawa S. Kakiuchi M, et al. Nat Genet. 2014 Jun;46(6):583-7. doi: 10.1038/ng.2984. Epub 2014 May 11. Nat Genet. 2014. PMID: 24816255
• Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.

  Tan P, Yeoh KG. Tan P, et al. Gastroenterology. 2015 Oct;149(5):1153-1162.e3. doi: 10.1053/j.gastro.2015.05.059. Epub 2015 Jun 12. Gastroenterology. 2015. PMID: 26073375 Review.